首页> 外文OA文献 >Phase Ib dose-finding trial of lapatinib plus pegylated liposomal doxorubicin in advanced HER2-positive breast cancer

【2h】

Phase Ib dose-finding trial of lapatinib plus pegylated liposomal doxorubicin in advanced HER2-positive breast cancer

机译：拉帕替尼联合聚乙二醇化脂质体阿霉素治疗晚期HER2阳性乳腺癌的Ib期剂量研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者

展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Phase Ib dose-finding trial of lapatinib plus pegylated liposomal doxorubicin in advanced HER2-positive breast cancer [J] . Rocca Andrea, Cecconetto Lorenzo, Passardi Alessandro, Cancer chemotherapy and pharmacology. . 2017,第5期

机译：Lapatinib Plus Pegymated脂质体DOXORUBICIN在高级HER2阳性乳腺癌中的IB剂量发现试验
2. Phase Ib dose-finding trial of lapatinib plus pegylated liposomal doxorubicin in advanced HER2-positive breast cancer [J] . Rocca Andrea, Cecconetto Lorenzo, Passardi Alessandro, Cancer chemotherapy and pharmacology. . 2017,第5期

机译：Lapatinib Plus Pegymated脂质体DOXORUBICIN在高级HER2阳性乳腺癌中的相位1b剂量发现试验
3. Lapatinib-plus-Pegylated Liposomal Doxorubicin in Advanced HER2-positive Breast Cancer Following Trastuzumab. A Phase II Trial [J] . Pircher Magdalena, Mlineritsch Brigitte, Fridrik Michael A., Anticancer Research: International Journal of Cancer Research and Treatment . 2015,第1期

机译：曲妥珠单抗治疗晚期HER2阳性乳腺癌中的拉帕替尼加聚乙二醇化脂质体阿霉素。第二阶段试验
4. COMPLEMENT ACTIVATION BY PEGYLATED LIPOSOMAL DOXORUBICIN (DOXIL~R) IN CANCER PATIENTS: ASSOCIATION WITH HYPERSENSITIVITY REACTIONS [C] . A. Chanan-Khan, J. Szebeni, L. Leibes, International symposium on controlled release of bioactive materials;Consumer diversified products conference . 2001

机译：聚脂脂质体阿霉素（DOXIL〜R）在癌症患者中的补体激活：与超敏反应的关联
5. A phase Ib study of safety and pharmacokinetics of trastuzumab emtansine and pertuzumab in Japanese patients with HER2-positive metastatic breast cancer [D] . NOGUCHI, Emi 2019

机译：Ib期研究曲妥珠单抗氨丹宁和帕妥珠单抗在日本HER2阳性转移性乳腺癌患者中的安全性和药代动力学
6. Phase Ib dose-finding trial of lapatinib plus pegylated liposomal doxorubicin in advanced HER2-positive breast cancer [O] . Andrea Rocca, Lorenzo Cecconetto, Alessandro Passardi, -1

机译：拉帕替尼联合聚乙二醇化脂质体阿霉素治疗晚期HER2阳性乳腺癌的Ib期剂量研究
7. Trastuzumab Emtansine Plus Non-Pegylated Liposomal Doxorubicin in HER2-Positive Metastatic Breast Cancer (Thelma): A Single-Arm, Multicenter, Phase Ib Trial [O] . Elena López-Miranda, José Manuel Pérez-García, Serena Di Cosimo, 2020

机译：Trastuzumab Emtansine加上HER2阳性转移性乳腺癌（Thelma）中的非聚乙二醇化脂质体DOXORUBICIN：单臂，多中心，相IB试验

Phase Ib dose-finding trial of lapatinib plus pegylated liposomal doxorubicin in advanced HER2-positive breast cancer

著录项

引文网络

相似文献

相关主题

期刊订阅